Herpes Research Today is a free monthly online journal that collates and summarizes the latest research about Herpes, including details on herpes simplex virus (hsv), genital, oral, symptoms, treatment. | ||||||||
|
Treatment of mice with anti-CD86 mAb reduces CD8+ T cell-mediated CTL activity and enhances ocular viral replication in HSV-1-infected mice.Osorio Y, Cai S, Ghiasi H Center for Neurobiology and Vaccine Development, Ophthalmology Research, Department of Surgery, CSMC Burns & Allen Research Institute, Los Angeles, CA 90048, USA. PURPOSE: To determine the relative impact of the CD86 (B7-2) costimulatory molecule in protection against ocular HSV-1 infection. METHODS: BALB/c mice were depleted of CD86 by antibody and depleted mice were examined for their ability to withstand HSV-1 ocular infection. Depleted mice were tested for the presence of virus replication, T-cell activation, survival, and eye disease. RESULTS: Mice that had been depleted of CD86 had significantly higher titers of HSV-1 in their eyes compared to mock-depleted infected mice. However, the levels of corneal scarring between the two groups of mice were similar. Following ocular infection, the levels of class I MHC-restricted cytotoxic T lymphocytes (CTL) were significantly higher in mock-depleted mice than in CD86-depleted mice. Finally, adoptive transfer of primed CD8(+) T cells but not CD4(+) T cells to CD86-depleted mice resulted in a decrease in peak virus titers in the eyes, such that HSV-1 titers were similar to that of their mock-depleted counterparts. CONCLUSIONS: These data demonstrate an important role for CD86 in the development of CTL and reduction of virus replication in the eyes of HSV-1-infected mice. Published 15 July 2005 in Ocul Immunol Inflamm, 13(2): 159-67.
© 2004-2008 Herpes Research Today. All Rights Reserved. |
| ||||||
